Clinical Trials Browser

Phase 1/2 × INDUSTRY × Advanced Squamous Non-Small Cell Lung Carcinoma × Clear all

NCT05127590 2023-07-03

RBN-2397 in Combination With Pembrolizumab in Patients With SCCL

Phase 1/2 Unknown

Advanced Squamous Non-Small Cell Lung Carcinoma